CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 3, July/August 2023 156 AFRICA Esteban MT, et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008; 29(13): 1670–1680. 27. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AAM. Sudden unexplained death. Circulation 2005; 112(2): 207–213. 28. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up. The ALTITUDE survival study. Circulation 2010; 122(23): 2359–2367. 29. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004; 110(25): 3760–3765. 30. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359(10): 1009–1017. 31. Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, et al. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol 2015; 31: 270–277. 32. Hindricks, J. Camm, B. Merkely, P. Raatikainen DOA. The EHRA White Book 2017. The Current Status of Cardiac Electrophysiology. 10th edn, 2017: 1–594. 33. Wójcicka M, Lewandowski M, Smolis-Bąk E, Szwed H. Psychological and clinical problems in young adults with implantable cardioverterdefibrillators. Kardiol Pol (Polish Heart J). 2008; 66(10): 1050–1058. 34. Lewandowski M, Sterliński M, Maciąg A, Syska P, Kowalik I, Szwed H, et al. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors’ own experience with optimal implantable cardioverter-defibrillator programming. EP Eur 2010; 12(9): 1245–1250. 35. Borne RT, Varosy PD, Masoudi FA. Implantable cardioverter-defibrillator shocks epidemiology, outcomes, and therapeutic approaches. J Am Med Assoc Intern Med 2013; 173(10): 859–865. 36. Ingles J, Sarina T, Kasparian N, Semsarian C. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol 2013; 168(4): 3779–3784. 37. Garnreiter JM. Implantable defibrillation therapy. Inappropriate ICD shocks in pediatric and congenital heart disease patients. J Innov Card Rhythm Manag 2017; 8(11): 2898–2906. 38. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104(7): 796–801. 39. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators. Circulation 2004; 110(17): 2591–2596. 40. Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, et al. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. Circ Arrhythmia Electrophysiol 2009; 2(2): 146–153. 41. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367(24): 2275–2283. Researchers confirm vitamin D link in CVD risk reduction Scientists say that their recent study, the largest of its kind, suggests a link between vitamin D levels and the risk of cardiovascular disease (CVD), which is one of the main causes of global deaths, and predicted to escalate as populations continue to age and chronic diseases become more common. Observational studies have consistently shown a link between vitamin D levels and the risk of CVD, reports The Guardian. However, randomised, controlled trials previously found no evidence that supplements prevented CVD events, possibly due to differences in trial design, which can affect results. However, after a randomised, controlled trial involving more than 21 000 people over 60 years, the researchers said the findings suggests vitamin D supplements could reduce the risk of major cardiovascular events. The study was published in the British Medical Journal. The Australian researchers said the absolute risk difference was small, but that this was the largest trial of its kind to date and that further evaluation was now warranted. ‘These findings indicate that vitamin D supplementation might reduce the incidence of major cardiovascular events,’ they wrote. More trials were needed, but they said it suggested that previous thinking that vitamin D supplements do not alter CVD risk was ‘premature’. The study, which was led by the QIMR Berghofer Medical Research Institute in Queensland as part of its population health programme, was carried out between 2014 and 2020 and involved 21 315 Australians aged 60 to 84 years who randomly received a vitamin D supplement or placebo taken orally at the beginning of each month for up to five years. During the trial, 1 336 people experienced a major cardiovascular event: 6.6% in the placebo group and 6% in the vitamin D group. The rate of major cardiovascular events was 9% lower in the vitamin D group compared with the placebo group, equivalent to 5.8 fewer events per 1 000 participants. The rate of heart attack was 19% lower in the vitamin D group, and there was no difference in stroke risk between the two groups. Overall, the researchers calculated that 172 people would need to take monthly vitamin D supplements to prevent one major cardiovascular event. They acknowledged limitations of the trial and said the findings might not apply to other populations. However, this was a large trial with extremely high retention and adherence, and almost complete data on cardiovascular events and mortality outcomes. Vitamin D helps regulate the amount of calcium and phosphate in the body. These nutrients are needed to keep bones, teeth and muscles healthy. Source: MedicalBrief 2023
RkJQdWJsaXNoZXIy NDIzNzc=